Epidemiological aspects of the incidence of thyroid cancer in the Russian Federation

Abstract

The results of an analysis of the incidence of thyroid cancer (thyroid cancer) in the Russian Federation (2008−2018) are presented. With increasing age, the incidence of thyroid cancer increases. Dominated by people aged 55 years and above (52.9%). Over the 10-year period (2008−2018), the increase in the “rough” indicator of the incidence of thyroid cancer was 49.03%, the standardized − 43.5%. The prevalence of thyroid cancer among the population of the Russian Federation in 2018 amounted to 114.1 per 100,000 population, which is 52.5% higher than in 2008 (74.8). This is due to several reasons: the demographic aging of the population, an increase in the incidence rate, and an improvement in the detection of the disease among the population (from 17.4% in 2008 to 34.3% in 2018). There was an increase in the share of thyroid cancer patients registered in oncological institutions of the Russian Federation for 5 years or more from the moment of diagnosis (from 61.6% to 68.8%, respectively), and the index of accumulation of patients with thyroid cancer (from 12.4 to 13.9 respectively). In the cohort of thyroid cancer patients, identified actively, the proportion of patients with a tumor process of stage I−II was 77.7%, and with a running tumor process (stage III−IV) — 21%. There is a differentiation of the territories of the Russian Federation both in terms of early detection and morphological verification of thyroid cancer, and the volume of radical treatment and the use of various methods for its implementation.

Keywords

thyroid gland / incidence / age / indicators / differentiation / territories

References

[1] Пузин С.Н., Шургая М.А., Дмитриева Н.В., и др. Эпидемиология инвалидности взрослого населения в Российской Федерации // Эпидемиология и вакцинопрофилактика. ― 2019. ― Т.18. ― №5. ― C. 14−23. [Puzin SN, Shurgaya MA, Dmitrieva NV, et al. Epidemiology of disability of adult population in the Russian Federation. Epidemiology & Vaccinal prevention. 2019;18(5):14-23. (In Russ.)] https://doi.org/10.31631/2073-3046-2019-18-5-14-23.

[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.

[3] Шургая М.А. Злокачественные новообразования: возрастные особенности эпидемиологии первичной инвалидности в Российской Федерации // Российский онкологический журнал. ― 2016. ― Т.21. ― №6. ― С. 319−324. [Shurgaya MA. Malignant neoplasms: the age peculiarities of the epidemiology of primary disability in the Russian Federation. Russian journal of oncology. 2016;21(6):319-324. (In Russ.)] https://doi.org/10.18821/1028-9984-2016-21-6-319-324.

[4] Анисимов В.Н., Серпов В.Ю., Финагентов А.В., Хавинсон В.Х. Новый этап развития геронтологии и гериатрии в России: проблемы создания системы гериатрической помощи. Ч. 2. Структура системы, научный подход // Успехи геронтологии. ― 2017. ― Т.30. ― №4. ― С. 486–497. [Anisimov VN, Serpov VYu, Finagentov AV, Khavinson VKh. A new stage of development of gerontology and geriatrics in Russia: problems o creation of a geriatric care system. Part 2. The structure of the system, scientific approach. Advances in gerontology. 2017;30(4):486-497. (In Russ.)]

[5] Распоряжение Правительства Российской Федерации от 5 февраля 2016 г. № 164-р «Об утверждении Стратегии действий в интересах граждан старшего поколения в Российской Федерации до 2025 года». [Order № 164-r of the Government of the Russian Federation «Ob utverzhdenii Strategii deystviy v interesakh grazhdan starshego pokoleniya v Rossiyskoy Federatsii do 2025 goda», dated 2016 February 5. (In Russ.)] Доступно по: https://mintrud.gov.ru/docs/government/173. Ссылка активна на 01.03.2020.

[6] Щербакова Е.М. Старение населения мира по оценкам ООН 2019 года // Демоскоп Weekly [интернет]. ― 2019. ― №837-838. [Shcherbakova EM. Stareniye naseleniya mira po otsenkam OON 2019 goda. Demoskop Weekly [Internet]. 2019;(837-838). (In Russ.)] Доступно по: http://www. demoscope.ru/weekly/2019/0837/index.php. Ссылка активна на 01.03.2020.

[7] World Health Organization. World report on ageing and health. WHO: Geneva, Switzerland; 2015. Available from: https://www.who.int/.

[8] Здравоохранение в России. 2019. Статистический сборник. ― М.: Росстат; 2019. ― 170 с. [Zdravookhranenie v Rossii. 2019. Statisticheskii sbornik. Moscow: Rosstat; 2019. 170 p. (In Russ).]

[9] Бржезовский В.Ж. Опухоли щитовидной железы. Опухоли головы и шеи / Под ред. А.И. Пачес. 5-е изд., доп. и перераб. ― М.: Практическая медицина, 2013. ― С. 339−359. [Brzhezovskiy VZh. Opukholi shchitovidnoy zhelezy. Opukholi golovy i shei. Ed by A.I. Paches. 5th ed. revised and updated. Moscow: Prakticheskaya meditsina; 2013. Р. 339-359. (In Russ.)]

[10] Петрова Г.В., Старинский В.В., Грецова О.П. Злокачественные новообразования щитовидной железы в России в 1994−2014 гг. // Онкология. Журнал им. П.А. Герцена. ― 2017. ― Т.6. ― №2. ― С. 33−36. [Petrova GV, Starinsky VV, Gretsova OP. Malignant thyroid neoplasms in Russia in 1994−2014. P.A. Herzen journal of Oncology. 2017;6(2):33-36. (In Russ.)] doi: 10.17116/onkolog20165633-36.

[11] Aschebrook-Kilfoy B, Schechter RB, Shih YC, et al. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev. 2013;22(7):1252-1259. https://doi.org/10.1158/1055-9965.EPI-13-0242.

[12] Haugen BR, Alexander EK, Bible KC, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. https://doi.org/10.1089/thy.2015.0020.

[13] Miftari R, Topçiu V, Nura A, Haxhibeqiri V. Management of the patient with aggressive and resistant papillary thyroid carcinoma. Med Arch. 2016;70(4):314-317. https://doi.org/10.5455/medarh.2016.70.314-317.

[14] NCCN Clinical Practice Guidelines in Oncology. Thyroid carcinoma. Version 1.2017. National Comprehensive Cancer Network; 2017. 133 р. Available from: https://www.klinikum.uni-muenchen.de/Schilddruesenzentrum/download/inhalt/Leitlinien/NCCN/thyroid_2017.pdf.

[15] Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). ― М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИРЦ» Минздрава России, 2019. ― 250 с. [Kaprin AD, Starinskiy VV, Petrova GV. Zlokachestvennyye novoobrazovaniya v Rossii v 2018 godu (zabolevayemost’ i smertnost’). Moscow: MNIOI im. P.A. Gertsena − filial FGBU «NMIRTS» Minzdrava Rossii; 2019. 250 р. (In Russ).]

RIGHTS & PERMISSIONS

Eco-Vector